Association of sex and age with the ceramide profile of adipose tissue in patients with coronary artery disease
Open Access
- 2 August 2026
- journal article
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 11 (3) , 27-36
Abstract
Background . Coronary artery disease (CAD) is associated with complex molecular changes in adipose tissue (AT) that go beyond simple energy storage. Current studies indicate the active participation of AT in metabolic regulation and secretion of bioactive lipid mediators, including ceramides, the role of which in CAD pathogenesis remains poorly understood, particularly with regard to age and sex differences. Aim. To characterize the ceramide profile in subcutaneous, epicardial and perivascular AT (SAT, EAT, PVAT) in patients with CAD, with regard to age and sex differences. Materials and Methods . A lipidomic study of the ceramide profile was conducted in SAT, EAT, PVAT samples obtained from 58 patients with CAD who underwent coronary artery bypass grafting (single-center prospective clinical study). The ceramide composition was analyzed by high-performance liquid chromatography with tandem mass spectrometric detection. Results . Ageand sex-related differences in the AT ceramide profile were identified. In men, the concentrations of cardionegative ceramides (Cer d18:1/14:0, Cer d18:1/18:0, Cer d18:1/20:0, Cer d18:1/22:0) and Cer d18:1/24:1 were higher (p < 0.05). In PVAT of men, the levels of Cer 14:0, 16:0 and 22:4 were increased (p < 0.001). In EAT and PVAT of women, increased levels of Cer 18:0 and 23:0 were noted (p < 0.05). In EAT and PAT of women, the concentrations of Cer 20:0, 22:0 and 24:1 were higher (p < 0.05). The highest levels of cardionegative ceramides were observed in PVAT of patients aged over 75 years. The ratio of cardionegative to cardioprotective ceramides was higher in EAT in individuals aged 60–74 years and in PVAT in those aged over 75 years. Conclusion. Significant sexand age-related differences in the AT ceramide profile of patients with CAD were identified, emphasizing the need to consider these factors when assessing cardiovascular risk. The data obtained may contribute to the development of new therapeutic strategies aimed at modulating the ceramide profile of AT to reduce cardiovascular risk.Keywords
This publication has 23 references indexed in Scilit:
- Residual risks and evolving atherosclerotic plaquesMolecular and Cellular Biochemistry, 2023
- Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health StudyClinical Chemistry, 2021
- Fat-Secreted Ceramides Regulate Vascular Redox State and Influence Outcomes in Patients With Cardiovascular DiseaseJACC, 2021
- Sex Differences in Adipose Tissue FunctionEndocrinology and Metabolism Clinics of North America, 2020
- The aging heartClinical Science, 2018
- Changes in Visceral Adipose Tissue Plasma Membrane Lipid Composition in Old Rats Are Associated With Adipocyte Hypertrophy With AgingThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2018
- Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterolEuropean Heart Journal, 2016
- Sphingolipid Content of Human Adipose Tissue: Relationship to Adiponectin and Insulin ResistanceObesity, 2012
- Membrane phospholipids, lipoxidative damage and molecular integrity: A causal role in aging and longevityBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2008
- Possible involvement of ceramide in the regulation of rat Leydig cell functionThe Journal of Steroid Biochemistry and Molecular Biology, 2000